Extract from the Register of European Patents

EP Citations: EP3390432

Cited inInternational search
Type:Patent literature
Publication No.:US2014093485  [Y]
 (MEDIN JEFFREY A et al.) [Y] 1-34 * paragraph [US2014093485]; figure 1; claims 2,17; sequence 42 *
Type:Non-patent literature
Publication information:[XI]   CARBONARO DENISE A ET AL: "Preclinical Demonstration of Lentiviral Vector-mediated Correction of Immunological and Metabolic Abnormalities in Models of Adenosine Deaminase Deficiency", March 2014, MOLECULAR THERAPY, VOL. 22, NR. 3, PAGE(S) 607-622, ISSN: 1525-0016(print), XP002766675 [X] 1-7,9-19,21-28,30-32,34 * abstract; page 607, column r, paragraph l - page 608, column l, paragraph 1 * * page 608, column r, paragraph 2 * * page 608, column r, paragraph l - page 609; figures 1-6 * * page 612, column r, paragraph l - page 615, column l, paragraph 3 * * page 618, column r, paragraph 4 - page 621, column l, paragraph 1 *[I] 8,29,33
DOI: http://dx.doi.org/10.1038/mt.2013.265
Type:Non-patent literature
Publication information:[Y]   CLAUDIA A MONTIEL-EQUIHUA ET AL: "The [beta]-Globin Locus Control Region in Combination With the EF1[alpha] Short Promoter Allows Enhanced Lentiviral Vector-mediated Erythroid Gene Expression With Conserved Multilineage Activity", MOLECULAR THERAPY, vol. 20, no. 7, 1 July 2012 (2012-07-01), pages 1400 - 1409, XP055088506, ISSN: 1525-0016, DOI: 10.1038/mt.2012.50 [Y] 1-34 * the whole document *
DOI: http://dx.doi.org/10.1038/mt.2012.50